|
| Richard Mitter | From the Cancer Research UK Lung Cancer Centre of Excellence (M.J.-H., Good Clinical Laboratory Practice Facility, University College London (UCL) Experimental Cancer Medicine Centre (H.L.L., UCL Cancer Institute, Francis Crick Institute, Royal Marsden Hospital (S. Turajlic), UCL Hospitals, UCL Respiratory, UCL (S.M.J.), North Middlesex University Hospital (G.A.), Royal Free Hospital (S. Khan), and UCL Cancer Research UK and Cancer Trials Centre (N.I., University of Leicester (D.A.M., Glenfield Hospital (A.N., and the Medical Research Center Toxicology Unit (J.L.Q.), the Institute of Cancer Studies, University of Manchester (F.B.), the Christie Hospital (F.B., University Hospital of South Manchester, and Cancer Research UK Manchester Institute (C.D.), Birmingham Heartlands Hospital, Queen Elizabeth Hospital (P.T., and Institute of Immunology and Immunotherapy, University of Birmingham (G.M.), Aberdeen University Medical School and Aberdeen Royal Infirmary, Barnet and Chase Farm Hospitals, Princess Alexandra Hospital, St. Luke's Cancer Centre, Ashford and St. Peters' Hospitals, Velindre Hospital (J.F.L.), University Hospital Llandough, University Hospital of Wales, and Cardiff University (R.A.), and Wellcome Trust Sanger Institute, and Big Data Institute, University of Oxford, Oxford (S.D.) - all in the United Kingdom the Center for Biological Sequence Analysis, Technical University of Denmark, Boston Children's Hospital and Harvard Medical School, Semmelweis University, Hungary (Z.S.) Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, University of Leuven |
| David A Moore | From the Cancer Research UK Lung Cancer Centre of Excellence (M.J.-H., Good Clinical Laboratory Practice Facility, University College London (UCL) Experimental Cancer Medicine Centre (H.L.L., UCL Cancer Institute, Francis Crick Institute, Royal Marsden Hospital (S. Turajlic), UCL Hospitals, UCL Respiratory, UCL (S.M.J.), North Middlesex University Hospital (G.A.), Royal Free Hospital (S. Khan), and UCL Cancer Research UK and Cancer Trials Centre (N.I., University of Leicester (D.A.M., Glenfield Hospital (A.N., and the Medical Research Center Toxicology Unit (J.L.Q.), the Institute of Cancer Studies, University of Manchester (F.B.), the Christie Hospital (F.B., University Hospital of South Manchester, and Cancer Research UK Manchester Institute (C.D.), Birmingham Heartlands Hospital, Queen Elizabeth Hospital (P.T., and Institute of Immunology and Immunotherapy, University of Birmingham (G.M.), Aberdeen University Medical School and Aberdeen Royal Infirmary, Barnet and Chase Farm Hospitals, Princess Alexandra Hospital, St. Luke's Cancer Centre, Ashford and St. Peters' Hospitals, Velindre Hospital (J.F.L.), University Hospital Llandough, University Hospital of Wales, and Cardiff University (R.A.), and Wellcome Trust Sanger Institute, and Big Data Institute, University of Oxford, Oxford (S.D.) - all in the United Kingdom the Center for Biological Sequence Analysis, Technical University of Denmark, Boston Children's Hospital and Harvard Medical School, Semmelweis University, Hungary (Z.S.) Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, University of Leuven |
| Fiona Blackhall | From the Cancer Research UK Lung Cancer Centre of Excellence (M.J.-H., Good Clinical Laboratory Practice Facility, University College London (UCL) Experimental Cancer Medicine Centre (H.L.L., UCL Cancer Institute, Francis Crick Institute, Royal Marsden Hospital (S. Turajlic), UCL Hospitals, UCL Respiratory, UCL (S.M.J.), North Middlesex University Hospital (G.A.), Royal Free Hospital (S. Khan), and UCL Cancer Research UK and Cancer Trials Centre (N.I., University of Leicester (D.A.M., Glenfield Hospital (A.N., and the Medical Research Center Toxicology Unit (J.L.Q.), the Institute of Cancer Studies, University of Manchester (F.B.), the Christie Hospital (F.B., University Hospital of South Manchester, and Cancer Research UK Manchester Institute (C.D.), Birmingham Heartlands Hospital, Queen Elizabeth Hospital (P.T., and Institute of Immunology and Immunotherapy, University of Birmingham (G.M.), Aberdeen University Medical School and Aberdeen Royal Infirmary, Barnet and Chase Farm Hospitals, Princess Alexandra Hospital, St. Luke's Cancer Centre, Ashford and St. Peters' Hospitals, Velindre Hospital (J.F.L.), University Hospital Llandough, University Hospital of Wales, and Cardiff University (R.A.), and Wellcome Trust Sanger Institute, and Big Data Institute, University of Oxford, Oxford (S.D.) - all in the United Kingdom the Center for Biological Sequence Analysis, Technical University of Denmark, Boston Children's Hospital and Harvard Medical School, Semmelweis University, Hungary (Z.S.) Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, University of Leuven |
| Dean A Fennell | From the Cancer Research UK Lung Cancer Centre of Excellence (M.J.-H., Good Clinical Laboratory Practice Facility, University College London (UCL) Experimental Cancer Medicine Centre (H.L.L., UCL Cancer Institute, Francis Crick Institute, Royal Marsden Hospital (S. Turajlic), UCL Hospitals, UCL Respiratory, UCL (S.M.J.), North Middlesex University Hospital (G.A.), Royal Free Hospital (S. Khan), and UCL Cancer Research UK and Cancer Trials Centre (N.I., University of Leicester (D.A.M., Glenfield Hospital (A.N., and the Medical Research Center Toxicology Unit (J.L.Q.), the Institute of Cancer Studies, University of Manchester (F.B.), the Christie Hospital (F.B., University Hospital of South Manchester, and Cancer Research UK Manchester Institute (C.D.), Birmingham Heartlands Hospital, Queen Elizabeth Hospital (P.T., and Institute of Immunology and Immunotherapy, University of Birmingham (G.M.), Aberdeen University Medical School and Aberdeen Royal Infirmary, Barnet and Chase Farm Hospitals, Princess Alexandra Hospital, St. Luke's Cancer Centre, Ashford and St. Peters' Hospitals, Velindre Hospital (J.F.L.), University Hospital Llandough, University Hospital of Wales, and Cardiff University (R.A.), and Wellcome Trust Sanger Institute, and Big Data Institute, University of Oxford, Oxford (S.D.) - all in the United Kingdom the Center for Biological Sequence Analysis, Technical University of Denmark, Boston Children's Hospital and Harvard Medical School, Semmelweis University, Hungary (Z.S.) Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, University of Leuven |
| Apostolos Nakas | From the Cancer Research UK Lung Cancer Centre of Excellence (M.J.-H., Good Clinical Laboratory Practice Facility, University College London (UCL) Experimental Cancer Medicine Centre (H.L.L., UCL Cancer Institute, Francis Crick Institute, Royal Marsden Hospital (S. Turajlic), UCL Hospitals, UCL Respiratory, UCL (S.M.J.), North Middlesex University Hospital (G.A.), Royal Free Hospital (S. Khan), and UCL Cancer Research UK and Cancer Trials Centre (N.I., University of Leicester (D.A.M., Glenfield Hospital (A.N., and the Medical Research Center Toxicology Unit (J.L.Q.), the Institute of Cancer Studies, University of Manchester (F.B.), the Christie Hospital (F.B., University Hospital of South Manchester, and Cancer Research UK Manchester Institute (C.D.), Birmingham Heartlands Hospital, Queen Elizabeth Hospital (P.T., and Institute of Immunology and Immunotherapy, University of Birmingham (G.M.), Aberdeen University Medical School and Aberdeen Royal Infirmary, Barnet and Chase Farm Hospitals, Princess Alexandra Hospital, St. Luke's Cancer Centre, Ashford and St. Peters' Hospitals, Velindre Hospital (J.F.L.), University Hospital Llandough, University Hospital of Wales, and Cardiff University (R.A.), and Wellcome Trust Sanger Institute, and Big Data Institute, University of Oxford, Oxford (S.D.) - all in the United Kingdom the Center for Biological Sequence Analysis, Technical University of Denmark, Boston Children's Hospital and Harvard Medical School, Semmelweis University, Hungary (Z.S.) Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, University of Leuven |
| Stefan C Dentro | From the Cancer Research UK Lung Cancer Centre of Excellence (M.J.-H., Good Clinical Laboratory Practice Facility, University College London (UCL) Experimental Cancer Medicine Centre (H.L.L., UCL Cancer Institute, Francis Crick Institute, Royal Marsden Hospital (S. Turajlic), UCL Hospitals, UCL Respiratory, UCL (S.M.J.), North Middlesex University Hospital (G.A.), Royal Free Hospital (S. Khan), and UCL Cancer Research UK and Cancer Trials Centre (N.I., University of Leicester (D.A.M., Glenfield Hospital (A.N., and the Medical Research Center Toxicology Unit (J.L.Q.), the Institute of Cancer Studies, University of Manchester (F.B.), the Christie Hospital (F.B., University Hospital of South Manchester, and Cancer Research UK Manchester Institute (C.D.), Birmingham Heartlands Hospital, Queen Elizabeth Hospital (P.T., and Institute of Immunology and Immunotherapy, University of Birmingham (G.M.), Aberdeen University Medical School and Aberdeen Royal Infirmary, Barnet and Chase Farm Hospitals, Princess Alexandra Hospital, St. Luke's Cancer Centre, Ashford and St. Peters' Hospitals, Velindre Hospital (J.F.L.), University Hospital Llandough, University Hospital of Wales, and Cardiff University (R.A.), and Wellcome Trust Sanger Institute, and Big Data Institute, University of Oxford, Oxford (S.D.) - all in the United Kingdom the Center for Biological Sequence Analysis, Technical University of Denmark, Boston Children's Hospital and Harvard Medical School, Semmelweis University, Hungary (Z.S.) Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, University of Leuven |
| John Le Quesne | From the Cancer Research UK Lung Cancer Centre of Excellence (M.J.-H., Good Clinical Laboratory Practice Facility, University College London (UCL) Experimental Cancer Medicine Centre (H.L.L., UCL Cancer Institute, Francis Crick Institute, Royal Marsden Hospital (S. Turajlic), UCL Hospitals, UCL Respiratory, UCL (S.M.J.), North Middlesex University Hospital (G.A.), Royal Free Hospital (S. Khan), and UCL Cancer Research UK and Cancer Trials Centre (N.I., University of Leicester (D.A.M., Glenfield Hospital (A.N., and the Medical Research Center Toxicology Unit (J.L.Q.), the Institute of Cancer Studies, University of Manchester (F.B.), the Christie Hospital (F.B., University Hospital of South Manchester, and Cancer Research UK Manchester Institute (C.D.), Birmingham Heartlands Hospital, Queen Elizabeth Hospital (P.T., and Institute of Immunology and Immunotherapy, University of Birmingham (G.M.), Aberdeen University Medical School and Aberdeen Royal Infirmary, Barnet and Chase Farm Hospitals, Princess Alexandra Hospital, St. Luke's Cancer Centre, Ashford and St. Peters' Hospitals, Velindre Hospital (J.F.L.), University Hospital Llandough, University Hospital of Wales, and Cardiff University (R.A.), and Wellcome Trust Sanger Institute, and Big Data Institute, University of Oxford, Oxford (S.D.) - all in the United Kingdom the Center for Biological Sequence Analysis, Technical University of Denmark, Boston Children's Hospital and Harvard Medical School, Semmelweis University, Hungary (Z.S.) Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, University of Leuven |
| Peter Van Loo | From the Cancer Research UK Lung Cancer Centre of Excellence (M.J.-H., Good Clinical Laboratory Practice Facility, University College London (UCL) Experimental Cancer Medicine Centre (H.L.L., UCL Cancer Institute, Francis Crick Institute, Royal Marsden Hospital (S. Turajlic), UCL Hospitals, UCL Respiratory, UCL (S.M.J.), North Middlesex University Hospital (G.A.), Royal Free Hospital (S. Khan), and UCL Cancer Research UK and Cancer Trials Centre (N.I., University of Leicester (D.A.M., Glenfield Hospital (A.N., and the Medical Research Center Toxicology Unit (J.L.Q.), the Institute of Cancer Studies, University of Manchester (F.B.), the Christie Hospital (F.B., University Hospital of South Manchester, and Cancer Research UK Manchester Institute (C.D.), Birmingham Heartlands Hospital, Queen Elizabeth Hospital (P.T., and Institute of Immunology and Immunotherapy, University of Birmingham (G.M.), Aberdeen University Medical School and Aberdeen Royal Infirmary, Barnet and Chase Farm Hospitals, Princess Alexandra Hospital, St. Luke's Cancer Centre, Ashford and St. Peters' Hospitals, Velindre Hospital (J.F.L.), University Hospital Llandough, University Hospital of Wales, and Cardiff University (R.A.), and Wellcome Trust Sanger Institute, and Big Data Institute, University of Oxford, Oxford (S.D.) - all in the United Kingdom the Center for Biological Sequence Analysis, Technical University of Denmark, Boston Children's Hospital and Harvard Medical School, Semmelweis University, Hungary (Z.S.) Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, University of Leuven |
| Charles Swanton | From the Cancer Research UK Lung Cancer Centre of Excellence (M.J.-H., Good Clinical Laboratory Practice Facility, University College London (UCL) Experimental Cancer Medicine Centre (H.L.L., UCL Cancer Institute, Francis Crick Institute, Royal Marsden Hospital (S. Turajlic), UCL Hospitals, UCL Respiratory, UCL (S.M.J.), North Middlesex University Hospital (G.A.), Royal Free Hospital (S. Khan), and UCL Cancer Research UK and Cancer Trials Centre (N.I., University of Leicester (D.A.M., Glenfield Hospital (A.N., and the Medical Research Center Toxicology Unit (J.L.Q.), the Institute of Cancer Studies, University of Manchester (F.B.), the Christie Hospital (F.B., University Hospital of South Manchester, and Cancer Research UK Manchester Institute (C.D.), Birmingham Heartlands Hospital, Queen Elizabeth Hospital (P.T., and Institute of Immunology and Immunotherapy, University of Birmingham (G.M.), Aberdeen University Medical School and Aberdeen Royal Infirmary, Barnet and Chase Farm Hospitals, Princess Alexandra Hospital, St. Luke's Cancer Centre, Ashford and St. Peters' Hospitals, Velindre Hospital (J.F.L.), University Hospital Llandough, University Hospital of Wales, and Cardiff University (R.A.), and Wellcome Trust Sanger Institute, and Big Data Institute, University of Oxford, Oxford (S.D.) - all in the United Kingdom the Center for Biological Sequence Analysis, Technical University of Denmark, Boston Children's Hospital and Harvard Medical School, Semmelweis University, Hungary (Z.S.) Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, University of Leuven |